105
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria

, , ORCID Icon, , , , , & ORCID Icon show all
Pages 225-232 | Received 31 Oct 2023, Accepted 26 Mar 2024, Published online: 10 Apr 2024